Secretory leukoprotease inhibitor augments hepatocyte growth factor production in human lung fibroblasts

American Journal of Respiratory Cell and Molecular Biology

Volumn 23, Issue 3, 2000, Pages 364-370

  Kikuchi, T ^a   Abe, T ^a   Yaekashiwa, M ^a   Tomonaga, Y ^a   Mitsuhashi, H ^a   Satoh, K ^a   Nakamura, T ^a   Nukiwa, T ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033823703     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.23.3.3942     Document Type: Article

References (40)

1. Antiproteases and lung defense
2. Kinetics of the inhibition of leukocyte elastase by the bronchial inhibitor
3. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor
4. Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoprotease inhibitor
5. Tissue distribution of antileukoprotease and lysozyme in humans
6. Secretory leukocyte protease inhibitor: A macrophage product induced by and antagonistic to bacterial lipopolysaccharide
7. Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor
8. Antibacterial activity of antileukoprotease
9. Secretory leukocyte protease inhibitor: A human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro
10. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription
11. 2, and matrix metalloproteinases
12. Suppression of macrophage responses to bacterial lipopolysaccharide by a non-secretory form of secretory leukocyte protease inhibitor
13. Administration of truncated secretory leukoprotease inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters
14. Emerging multipotent aspects of hepatocyte growth factor
15. Regulation of scatter factor production via a soluble inducing factor
16. The cloning and characterization of a murine secretory leukocyte protease inhibitor cDNA
17. Bacterial pneumonia causes augmented expression of the secretory leukoprotease inhibitor gene in the murine lung
18. Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin
19. Efficient production of the C-terminal domain of secretory leukoprotease inhibitor as a thrombin-cleavable fusion protein in Escherichia coli
20. Synthesis of a gene for human growth hormone and its expression in Escherichia coli
21. Up-regulation of hepatocyte growth factor gene expression by interleukin-1 in human skin fibroblasts
22. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
23. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene
24. Oxidized mucus proteinase inhibitor: A fairly potent neutrophil elastase inhibitor
25. The 2.5 X-ray crystal structure of the acid-stable proteinase inhibitor from human mucous secretions analyzed in its complex with bovine α-chymotrypsin
26. Location of the protease-inhibitory region of secretory leukocyte protease inhibitor
27. Specific cleavage of secretory leukoprotease inhibitor by neutrophil elastase and saliva
28. Enhancement of human hepatocyte growth factor production by interleukin-1α and -1β and tumor necrosis factor-α by fibroblasts in culture
29. Novel function of prostaglandins as inducers of gene expression of HGF and putative mediators of tissue regeneration
30. ONO-5046, a novel inhibitor of human neutrophil elastase
31. Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells
32. 2 production, in human synovial fibroblasts
33. Contractility, transforming growth factor-β, and plasmin in fetal skin fibroblasts: Role in scarless wound healing
34. Molecular cloning of fibroblast activation protein α, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers
35. Characterization and determination of the relative abundance of two types of insulin-like growth factor binding protein-5 proteases that are secreted by human fibroblasts
36. Expression of serine proteinases and metalloproteinases in organ-cultured human skin: Altered levels in the presence of retinoic acid and possible relationship to retinoid-induced loss of epidermal cohesion
37. Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman-Birk protease inhibitor
38. Purification and characterization of a novel calcium-dependent serine proteinase secreted from malignant hamster embryo fibroblast Nil2C2
39. 1-proteinase inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters
40. Identification of a serpin-enzyme complex receptor on human hepatoma cells and human monocytes